EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Ginsenoside Rb3 ameliorates podocyte injury under hyperlipidemic conditions via PPARδ- or SIRT6-mediated suppression of inflammation and oxidative stress

Heeseung Oh, Wonjun Cho, Seung Yeon Park, A M Abd El-Aty, Ji Hoon Jeong, Tae Woo Jung

Journal of Ginseng Research · 2023-05 · 47 (3) · 400-407

DOI: 10.1016/j.jgr.2022.11.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ginseng Research, 2023-05. Verfasst von Heeseung Oh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science, ICT and Future Planning.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rb3 is a ginsenoside with anti-inflammatory properties in many cell types and has been reported to attenuate inflammation-related metabolic diseases such as insulin resistance, nonalcoholic fatty liver disease, and cardiovascular disease. However, the effect of Rb3 on podocyte apoptosis under hyperlipidemic conditions, which contributes to the development of obesity-mediated renal disease, remains unclear. In the current study, we aimed to investigate the effect of Rb3 on podocyte apoptosis in the presence of palmitate and explore its underlying molecular mechanisms.

Methods

Human podocytes (CIHP-1 cells) were exposed to Rb3 in the presence of palmitate as a model of hyperlipidemia. Cell viability was assessed by MTT assay. The effects of Rb3 on the expression of various proteins were analyzed by Western blotting. Apoptosis levels were determined by MTT assay, caspase 3 activity assay, and cleaved caspase 3 expression.

Results

We found that Rb3 treatment alleviated the impairment of cell viability and increased caspase 3 activity as well as inflammatory markers in palmitate-treated podocytes. Treatment with Rb3 dose-dependently increased PPARδ and SIRT6 expression. Knockdown of PPARδ or SIRT6 reduced the effects of Rb3 on apoptosis as well as inflammation and oxidative stress in cultured podocytes.

Conclusions

The current results suggest that Rb3 alleviates inflammation and oxidative stress via PPARδ- or SIRT6-mediated signaling, thereby attenuating apoptosis in podocytes in the presence of palmitate. The present study provides Rb3 as an effective strategy for treating obesity-mediated renal injury.

Schlagwörter

Stichwörter der Autor:innen

PPARδRb3SIRT6apoptosispodocytesrenal injury

Autor:innen und Institutionen

  • Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.
  • Department of Global Innovative Drugs, Graduate School of Chung-Ang University, Seoul, Republic of Korea.
  • Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
  • Department of Medical Pharmacology, Medical Faculty, Ataturk University, Erzurum, Turkey.

Förderung

  • National Research Foundation of Korea
  • Ministry of Science, ICT and Future Planning

Zitieren

APA

Oh, H., Cho, W., Park, S. Y., Abd El-Aty, A. M., Jeong, J. H., & Jung, T. W. (2023). Ginsenoside Rb3 ameliorates podocyte injury under hyperlipidemic conditions via PPARδ- or SIRT6-mediated suppression of inflammation and oxidative stress. Journal of Ginseng Research, 47(3), 400-407. https://doi.org/10.1016/j.jgr.2022.11.006

Vancouver

Oh H, Cho W, Park SY, Abd El-Aty AM, Jeong JH, Jung TW. Ginsenoside Rb3 ameliorates podocyte injury under hyperlipidemic conditions via PPARδ- or SIRT6-mediated suppression of inflammation and oxidative stress. Journal of Ginseng Research. 2023;47(3):400-407. doi:10.1016/j.jgr.2022.11.006

BibTeX
@article{Oh2023,
  author = {Oh, Heeseung and Cho, Wonjun and Park, Seung Yeon and Abd El-Aty, A M and Jeong, Ji Hoon and Jung, Tae Woo},
  title = {Ginsenoside Rb3 ameliorates podocyte injury under hyperlipidemic conditions via PPARδ- or SIRT6-mediated suppression of inflammation and oxidative stress},
  journal = {Journal of Ginseng Research},
  year = {2023},
  volume = {47},
  number = {3},
  pages = {400--407},
  doi = {10.1016/j.jgr.2022.11.006}
}
Kostenlos starten →